Viewing Study NCT02093403


Ignite Creation Date: 2025-12-24 @ 7:13 PM
Ignite Modification Date: 2026-01-05 @ 6:31 PM
Study NCT ID: NCT02093403
Status: COMPLETED
Last Update Posted: 2017-12-08
First Post: 2014-03-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Decitabine and Selinexor in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
Sponsor: Bhavana Bhatnagar
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module